![](https://cdn.statically.io/img/news.unchealthcare.org/wp-content/uploads/sites/1159/2024/05/McELLIGOTT-ZOE-600x400.jpg)
May 13, 2024
Scientists Discover Surprising Details about Xylazine in Combination with Fentanyl
The UNC School of Medicine lab of Zoe McElligott, PhD, and colleagues found that the animal tranquilizer xylazine activates opioid receptors in the brain, suggesting a reason why the treatment naloxone triggers a more severe withdrawal response when given to individuals on fentanyl/xylazine and suffering from respiratory depression.